IFN-γ inhibits IL-4-induced type 2 cytokine expression by CD8 T cells in vivo and modulates the anti-tumor response

Journal of Immunology

Volumn 185, Issue 2, 2010, Pages 998-1004

  Apte, Simon H ^a,b   Groves, Penny ^a,b   Olver, Stuart ^a,b   Baz, Adriana ^a,b,c   Doolan, Denise L ^a   Kelso, Anne ^a,b,d   Kienzle, Norbert ^a,b,e  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b The Cooperative Research Centre for Vaccine Technology   (Australia)

^c CSL LIMITED   (Australia)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e Arana Therapeutics   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; TRANSCRIPTION FACTOR GATA 3; TYPE 2 CYTOKINE; UNCLASSIFIED DRUG; GATA3 PROTEIN, MOUSE; INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMETRY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; TUMOR CELL; ANIMAL; C57BL MOUSE; CYTOLOGY; EXPERIMENTAL NEOPLASM; FLOW CYTOMETRY; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CYTOKINES; FLOW CYTOMETRY; GATA3 TRANSCRIPTION FACTOR; GENE EXPRESSION; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-4; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASMS, EXPERIMENTAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77955506879     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903372     Document Type: Article

References (32)

1. + T cells. J. Leukoc. Biol. 81: 1102-1110.
2. + T cell proliferation. J. Immunol. 182: 1429-1438.
3. Kienzle, N., K. Buttigieg, P. Groves, T. Kawula, and A. Kelso. 2002. A clonal culture system demonstrates that IL-4 induces a subpopulation of noncytolytic T cells with low CD8, perforin, and granzyme expression. J. Immunol. 168: 1672-1681. (Pubitemid 34135763)
4. low phenotype in the presence of IL-4. J. Immunol. 174: 2021-2029.
5. Luescher, I. F., E. Vivier, A. Layer, J. Mahiou, F. Godeau, B. Malissen, and P. Romero. 1995. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature 373: 353-356.
6. - cells that make TH2 cytokines and help B cells. Science 260: 1802-1805.
7. + T cells. Proc. Natl. Acad. Sci. USA 105: 17475-17480.
8. + T cells is required for the development of protective memory responses against liver stages of malaria parasites. J. Exp. Med. 202: 551-560.
9. + T cells can be primed in vitro to produce IL-4. J. Immunol. 148: 1652-1656.
10. + T cells secreting Th1 or Th2 cytokines. Immunity 2: 271-279.
11. + T cells showing B cell helper function and reduced cytolytic activity in human immunodeficiency virus type 1 infection. J. Exp. Med. 180: 489-495.
12. Dobrzanski, M. J., J. B. Reome, and R. W. Dutton. 2001. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection. J. Immunol. 167: 424-434.
13. Carter, L. L., and R. W. Dutton. 1995. Relative perforin- and Fas-mediated lysis in T1 and T2 CD8 effector populations. J. Immunol. 155: 1028-1031.
14. Cerwenka, A., T. M. Morgan, A. G. Harmsen, and R. W. Dutton. 1999. Migration kinetics and final destination of type 1 and type 2 CD8 effector cells predict protection against pulmonary virus infection. J. Exp. Med. 189: 423-434.
15. + T cells and induces synthesis of IL-3 and IFN-γ but not IL-4 or IL-6. Int. Immunol. 4: 475-485.
16. Lahm, H. W., and S. Stein. 1985. Characterization of recombinant human interleukin-2 with micromethods. J. Chromatogr. 326: 357-361. (Pubitemid 15069382)
17. + T cells. Cancer Res. 66: 571-580.
18. + T cells activated in vitro is affected by culture conditions and correlates with effector activity. Immunology 115: 315-324.
19. Lighvani, A. A., D. M. Frucht, D. Jankovic, H. Yamane, J. Aliberti, B. D. Hissong, B. V. Nguyen, M. Gadina, A. Sher, W. E. Paul, and J. J. O'Shea. 2001. T-bet is rapidly induced by interferon-γ in lymphoid and myeloid cells. Proc. Natl. Acad. Sci. USA 98: 15137-15142.
20. Zheng, W., and R. A. Flavell. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89: 587-596.
21. Miaw, S. C., A. Choi, E. Yu, H. Kishikawa, and I. C. Ho. 2000. ROG, repressor of GATA, regulates the expression of cytokine genes. Immunity 12: 323-333.
22. Omori, M., M. Yamashita, M. Inami, M. Ukai-Tadenuma, M. Kimura, Y. Nigo, H. Hosokawa, A. Hasegawa, M. Taniguchi, and T. Nakayama. 2003. CD8 T cell-specific downregulation of histone hyperacetylation and gene activation of the IL-4 gene locus by ROG, repressor of GATA. Immunity 19: 281-294. (Pubitemid 37011342)
23. Huang, Z., J. Xin, J. Coleman, and H. Huang. 2005. IFN-γ suppresses STAT6 phosphorylation by inhibiting its recruitment to the IL-4 receptor. J. Immunol. 174: 1332-1337.
24. Dobrzanski, M. J., J. B. Reome, J. A. Hollenbaugh, and R. W. Dutton. 2004. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses. J. Immunol. 172: 1380-1390.
25. + effector T cell subpopulations promote long-term tumor immunity and protection to progressively growing tumor. J. Immunol. 164: 916-925.
26. Helmich, B. K., and R. W. Dutton. 2001. The role of adoptively transferred CD8 T cells and host cells in the control of the growth of the EG7 thymoma: factors that determine the relative effectiveness and homing properties of Tc1 and Tc2 effectors. J. Immunol. 166: 6500-6508.
27. Rodolfo, M., C. Zilocchi, P. Accornero, B. Cappetti, I. Arioli, and M. P. Colombo. 1999. IL-4 - transduced tumor cell vaccine induces immunoregulatory type 2 CD8 T lymphocytes that cure lung metastases upon adoptive transfer. J. Immunol. 163: 1923-1928.
28. Haridas, V., and R. K. Saxena. 1995. Role of major histocompatibility complex class I antigens in modulating the performance of murine tumour cells in cold target competition assays. Immunology 84: 86-90.
29. Salgame, P., J. S. Abrams, C. Clayberger, H. Goldstein, J. Convit, R. L. Modlin, and B. R. Bloom. 1991. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254: 279-282.
30. + T cells from patients with tuberculosis is related to the presence of pulmonary cavities. J. Infect. Dis. 181: 1194-1197.
31. + T cells in response to Mycobacterium tuberculosis in tuberculosis patients. Tuberculosis 82: 7-13.
32. Scrivener, S., R. V. Goddard, E. R. Kaminski, and A. G. Prentice. 2003. Abnormal T-cell function in B-cell chronic lymphocytic leukaemia. Leuk. Lymphoma 44: 383-389.